User login
The 2022 CHEST Annual Meeting had several important studies on lung cancer.
Douglas Arenberg, MD, FCCP from the University of Michigan Northville Health Center, reports on content from two papers that focus on the first million persons to have been screened for lung cancer after the initial launch of the American College of Radiology Lung Cancer Screening Registry. The research showed that the medical community is, in fact, doing well in some areas of lung cancer screening but that improvements need to be made in order to reach former tobacco users, who would greatly benefit from these screenings.
He also highlights a series of studies that were discussed regarding smoking cessation at lung evaluations known as the SCALE Collaboration. Effective smoking interventions could enhance the benefits of lung cancer screening by reducing mortality and morbidity resulting from lung cancer.
Finally, Dr Arenberg shares a series of presentations that highlight how the surgical treatment of early-stage lung cancer is creating significant changes in the standard of care.
--
Douglas Arenberg, MD, FCCP Professor of Medicine, Department of Internal Medicine, Division of Pulmonary & Critical Care, University of Michigan; Director of Bronchoscopy and Medical Director for the Lung Cancer Screening and Lung Nodule Clinics, University of Michigan, Ann Arbor, Michigan
Douglas Arenberg, MD, FCCP has disclosed no relevant financial relationships.
The 2022 CHEST Annual Meeting had several important studies on lung cancer.
Douglas Arenberg, MD, FCCP from the University of Michigan Northville Health Center, reports on content from two papers that focus on the first million persons to have been screened for lung cancer after the initial launch of the American College of Radiology Lung Cancer Screening Registry. The research showed that the medical community is, in fact, doing well in some areas of lung cancer screening but that improvements need to be made in order to reach former tobacco users, who would greatly benefit from these screenings.
He also highlights a series of studies that were discussed regarding smoking cessation at lung evaluations known as the SCALE Collaboration. Effective smoking interventions could enhance the benefits of lung cancer screening by reducing mortality and morbidity resulting from lung cancer.
Finally, Dr Arenberg shares a series of presentations that highlight how the surgical treatment of early-stage lung cancer is creating significant changes in the standard of care.
--
Douglas Arenberg, MD, FCCP Professor of Medicine, Department of Internal Medicine, Division of Pulmonary & Critical Care, University of Michigan; Director of Bronchoscopy and Medical Director for the Lung Cancer Screening and Lung Nodule Clinics, University of Michigan, Ann Arbor, Michigan
Douglas Arenberg, MD, FCCP has disclosed no relevant financial relationships.
The 2022 CHEST Annual Meeting had several important studies on lung cancer.
Douglas Arenberg, MD, FCCP from the University of Michigan Northville Health Center, reports on content from two papers that focus on the first million persons to have been screened for lung cancer after the initial launch of the American College of Radiology Lung Cancer Screening Registry. The research showed that the medical community is, in fact, doing well in some areas of lung cancer screening but that improvements need to be made in order to reach former tobacco users, who would greatly benefit from these screenings.
He also highlights a series of studies that were discussed regarding smoking cessation at lung evaluations known as the SCALE Collaboration. Effective smoking interventions could enhance the benefits of lung cancer screening by reducing mortality and morbidity resulting from lung cancer.
Finally, Dr Arenberg shares a series of presentations that highlight how the surgical treatment of early-stage lung cancer is creating significant changes in the standard of care.
--
Douglas Arenberg, MD, FCCP Professor of Medicine, Department of Internal Medicine, Division of Pulmonary & Critical Care, University of Michigan; Director of Bronchoscopy and Medical Director for the Lung Cancer Screening and Lung Nodule Clinics, University of Michigan, Ann Arbor, Michigan
Douglas Arenberg, MD, FCCP has disclosed no relevant financial relationships.
